Presentations
back to blog

AI-driven discovery of 1000-fold selective and CNS-penetrant Her2 inhibitor

Presentations
This is some text inside of a div block.
January 31, 2024

Media Contacts

Related announcements

View All
View All
November 1, 2024

Previewing NeuralPLexer3: Towards fully AI-enabled Structure-Based Drug Discovery

Read more
November 1, 2024

Previewing NeuralPLexer3: Towards fully AI-enabled Structure-Based Drug Discovery

Read more
October 29, 2024

Iambic Therapeutics Announces “Enchant,” an AI Platform that Predicts Clinical Outcomes from the Earliest Stages of Drug Discovery

Read more
October 29, 2024

Iambic Therapeutics Announces “Enchant,” an AI Platform that Predicts Clinical Outcomes from the Earliest Stages of Drug Discovery

Read more
October 29, 2024

Enchant whitepaper: Breaking the data wall between lab and clinic

Read more
October 29, 2024

Enchant whitepaper: Breaking the data wall between lab and clinic

Read more